Azathioprine response in patients with fibrotic connective tissue disease-associated interstitial lung disease
Justin M. Oldham(Michigan Medicine), Mary E. Strek(University of Chicago), Rekha Vij(University of Chicago), Jonathan H. Chung(National Jewish Health), Scully Hsu(University of Chicago), Eleanor Valenzi(University of Pittsburgh), Cathryn Lee(University of Chicago), Ayodeji Adegunsoye(University of Chicago), Lena W. Chen(University of Chicago), Imre Noth(University of Virginia), Leah J. Witt(University of Chicago), Steven M. Montner(University of Chicago)
Cited by 109
Related Papers
Immunology of COVID-19: Current State of the Science
|Immunity|2020|1.8k
Diagnosis of Hypersensitivity Pneumonitis in Adults: An Official ATS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2020|1k
Association Between the MUC5B Promoter Polymorphism and Survival in Patients With Idiopathic Pulmonary Fibrosis
|JAMA|2013|456
Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease
|European Respiratory Journal|2015|393
PD-1 up-regulation on CD4 <sup>+</sup> T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-β1 production
|Science Translational Medicine|2018|364